Discover how Unicorn Biotechnologies is revolutionizing lab workflows with cell culture automation. Expert insights from ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

Rational Dynamic Brands Fund earns a Below Average Process Pillar rating. The process is strengthened by the firm's retention rate of the firm's portfolio managers, which is 89% over the available ...

Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month. Nasdaq provides call ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical ...

Only in Newsday Sources: Detective owns LI home where body was found in pool A member of the task force that searched for homicide suspect Matthew Zoll last November owns the East Shoreham home ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

May 27, 2025 — A new study reveals the biological secret to the Zika virus's infectious success: Zika uses host cells' own 'self-care' system of clearing away useless molecules to suppress the ...

Novo Nordisk has reached an agreement to buy Germany’s Cardior Pharmaceuticals for €1.025 billion ($1.1 billion), adding expertise in RNA therapeutics and a heart failure therapy in mid-stage ...

The trend has been historically high with biotech start-ups and is growing rapidly with digital health start-ups in US, Europe, and Asia. Although these deals are increasingly commonplace (and for ...